Global Networking Against Malaria

Announcements Calendar RBM MIM Networks and Databases More on the Web News About MFI DAM Home

Bibliography

Research Toward a Malaria Vaccine

This is a bibliography of references concerning research toward a malaria vaccine. References are added as time permits. This bibliography is not comprehensive at this time. Owing to size, this bibliography is split into two pages. An older bibliography is at National Library of Medicine.





  1. Nardin E, Zavala F, Nussenzweig V, Nussenzweig RS. 1999. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials. Parassitologia. 41(1-3):397-402. Abstract.
  2. Narum, D.L., J.D. Haynes, S. Fuhrmann, K. Moch, H. Liang, S.L. Hoffman, and B.K. Sim. 2000. Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids. Infect. Immun. 68(4):1964-1966. Abstract.
  3. Nguer, C.M., A. Diouf, T.O. Diallo, A. Dieye, A. Tall, B. Diouf, J.F. Molez, J.F. Trape, R. Perraut, and O. Garraud. 1997. [Specific antibodies against Plasmodium falciparum antigens in immune subjects: II. Screening of responses against the merozoite major surface antigen]. [in French]. Dakar Med. 42(2):106-110. Abstract.
  4. Nikodem, D., and E. Davidson. 2000. Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro. Mol. Biochem. Parasitol. 108(1):79-91. Abstract.
  5. O'Donnell, R.A., A. Saul, A.F. Cowman, and B.S. Crabb. 2000. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species. Nat. Med. 6(1):91-95. Abstract.
  6. Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR, et al. 1998. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J. Infect. Dis. 177(6):1664-1673. Abstract.
  7. Pan, W., E. Ravot, R. Tolle, R. Frank, R. Mosbach, I. Turbachova, and H. Bujard. 1999. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells. Nucleic Acids Res. 27(4):1094-1103. Abstract. Abstract from publisher.
  8. Parra, M., G. Hui, A.H. Johnson, J.A. Berzofsky, T. Roberts, T.A. Quakyi, and D.W. Taylor. 2000. Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1. Infect. Immun. 68(5):2685-2691. Abstract.
  9. Pye D, Vandenberg KL, Dyer SL, Irving DO, Goss NH, Woodrow GC, Saul A, Alving CR, Richards RL, Ballou WR, Wu MJ, Skoff K, Anders RF. 1997. Selection of an adjuvant for vaccination with the malaria antigen, MSA-2. Vaccine. 15(9):1017-1023. Abstract.
  10. Ramasamy, R., S.G. Yasawardena, R. Kanagaratnam, E. Buratti, F.E. Baralle, and M.S. Ramasamy. 1999. Mammalian cell expression of malaria merozoite surface proteins and experimental DNA and RNA immunisation. Biochim. Biophys. Acta. 1453(1):1-13. Abstract.
  11. Ranjit, M.R., and Y.D. Sharma. 1999. Genetic polymorphism of falciparum malaria vaccine candidate antigen genes among field isolates in India. Amer. J. Trop. Med. Hyg. 61(1):103-108. Abstract.
  12. Rotman, H.L., T.M. Daly, and C.A. Long. 1999. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge. Exp. Parasitol. 91(1):78-85. Abstract. Abstract from publisher.
  13. Sakihama, N., M. Kimura, K. Hirayama, T. Kanda, K. Na-Bangchang, S. Jongwutiwes, D. Conway, and K. Tanabe. 1999. Allelic recombination and linkage disequilibrium within Msp-1 of Plasmodium falciparum, the malignant human malaria parasite. Gene. 230(1):47-54. Abstract.
  14. Saul A, Lawrence G, Smillie A, Rzepczyk CM, Reed C, Taylor D, Anderson K, Stowers A, Kemp R, Allworth A, Anders RF, Brown GV, Pye D, Schoofs P, Irving DO, Dyer SL, Woodrow GC, Briggs WR, Reber R, and Sturchler D. 1999. Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant. Vaccine. 17(23-24):3145-3159. Abstract.
  15. Sherwood JA, Copeland RS, Taylor KA, Abok K, Oloo AJ, Were JB, Strickland GT, Gordon DM, Ballou WR, Bales JD Jr, Wirtz RA, Wittes J, Gross M, Que JU, Cryz SJ, Oster CN, Roberts CR, Sadoff JC. 1996. Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya. Vaccine. 14(8):817-827. Abstract.
  16. Sherwood JA, Oster CN, Adoyo-Adoyo M, Beier JC, Gachihi GS, Nyakundi PM, Ballou WR, Brandling-Bennett AD, Schwartz IK, Were JB, et al. 1991. Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural exposure to malaria. Trans. R. Soc. Trop. Med. Hyg. 85(3):336-340. Abstract.
  17. Shi, Y.P., P. Das, B. Holloway, V. Udhayakumar, J.E. Tongren, F. Candal, S. Biswas, R. Ahmad, S.E. Hasnain, and A.A. Lal. 2000. Development, expression, and murine testing of a multistage Plasmodium falciparum malaria vaccine candidate. Vaccine. 18(25):2902-2914. Abstract.
  18. Shi YP, Hasnain SE, Sacci JB, Holloway BP, Fujioka H, Kumar N, Wohlhueter R, Hoffman SL, Collins WE, and Lal AA. 1999. Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc. Natl. Acad. Sci. U. S. A. 96(4):1615-1620. Abstract.
  19. Snounou, G., X. Zhu, N. Siripoon, W. Jarra, S. Thaithong, K.N. Brown, and S. Viriyakosol S. 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans. R. Soc. Trop. Med. Hyg. 93(4):369-374. Abstract.
  20. Soares, I.S., M.G. da Cunha, M.N. Silva, J.M. Souza, H.A. Del Portillo, and M.M. Rodrigues. 1999. Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1. Amer. J. Trop. Med. Hyg. 60(3):357-363. Abstract
  21. Sokhna, C.S., C. Rogier, A. Dieye, and J.F. Trape. 2000. Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission. Amer. J. Trop. Med. Hyg. 62(2):266-270. Abstract.
  22. Somner, E.A., S.A. Ogun, K.A. Sinha, L.M. Spencer Valero, J.J. Lee, J.A. Harrison, A.A. Holder, C.E. Hormaeche, and C.M. Khan. 1999. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains. Microbiology. 145 (Pt. 1):221-229. Abstract.
  23. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U, and Marchand M. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N. Engl. J. Med. 336(2):86-91. Abstract. Abstract from publisher.
  24. Sturchler D, Berger R, Etlinger H, Fernex M, Matile H, Pink R, Schlumbom V, and Just M. 1989. Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults. Vaccine. 7(5):457-461. Abstract.
  25. Tanabe, K., N. Sakihama, O. Kaneko, A. Saito-Ito, and M. Kimura. 1998. A PCR method for molecular epidemiology of Plasmodium falciparum Msp-1. Tokai J. Exp. Clin. Med. 23(6):375-381. Abstract.
  26. Tanabe, K., N. Sakihama, Y. Nakamura, O. Kaneko, M. Kimura, M.U. Ferreira, and K. Hirayama. 2000. Selection and genetic drift of polymorphisms within the merozoite surface protein-1 gene of Plasmodium falciparum. Gene. 241(2):325-331. Abstract.
  27. Waller, K.L., B.M. Cooke, W. Nunomura, N. Mohandas, and R.L. Coppel. 1999. Mapping the binding domains involved in the interaction between the Plasmodium falciparum knob-associated histidine-rich protein (KAHRP) and the cytoadherence ligand P. falciparum erythrocyte membrane protein 1 (PfEMP1). J. Biol. Chem. 274(34):23808-23813. Abstract.
  28. Zhong, H., J.Y. Fan, S. Yang, and E.A. Davidson. 1999. Cloning and characterization of the merozoite surface antigen 1 gene of Plasmodium berghei. Amer. J. Trop. Med. Hyg. 60(6):994-999. Abstract.





Back to References

Last Revised 12 September 2000


Thank you for visiting the MFI Site!


Copyright © 1999-2000
Malaria Foundation International
All Rights Reserved.